KR100221031B1 - 생물학적으로 활성 단백질, 펩티드 또는 폴리펩티드를 함유하는 이식재 조성물 및 그의 제조 방법 - Google Patents

생물학적으로 활성 단백질, 펩티드 또는 폴리펩티드를 함유하는 이식재 조성물 및 그의 제조 방법 Download PDF

Info

Publication number
KR100221031B1
KR100221031B1 KR1019920010911A KR920010911A KR100221031B1 KR 100221031 B1 KR100221031 B1 KR 100221031B1 KR 1019920010911 A KR1019920010911 A KR 1019920010911A KR 920010911 A KR920010911 A KR 920010911A KR 100221031 B1 KR100221031 B1 KR 100221031B1
Authority
KR
South Korea
Prior art keywords
composition
biologically active
peptide
polypeptide
active protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019920010911A
Other languages
English (en)
Korean (ko)
Other versions
KR930000131A (ko
Inventor
데이빗 스테버 윌리엄
맨시니 캐디 수잔
파아리 존슨 데이빗
라이스 서레사
Original Assignee
윌리암 에이취 캘넌
아메리칸사이아나미드컴퍼니
에곤 이버그
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 에이취 캘넌, 아메리칸사이아나미드컴퍼니, 에곤 이버그 filed Critical 윌리암 에이취 캘넌
Publication of KR930000131A publication Critical patent/KR930000131A/ko
Application granted granted Critical
Publication of KR100221031B1 publication Critical patent/KR100221031B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/10—Stiffening bandages containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
KR1019920010911A 1991-06-24 1992-06-23 생물학적으로 활성 단백질, 펩티드 또는 폴리펩티드를 함유하는 이식재 조성물 및 그의 제조 방법 Expired - Fee Related KR100221031B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71989891A 1991-06-24 1991-06-24
US7/719898 1991-06-24
US07/719898 1991-06-24

Publications (2)

Publication Number Publication Date
KR930000131A KR930000131A (ko) 1993-01-15
KR100221031B1 true KR100221031B1 (ko) 1999-09-15

Family

ID=24891827

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920010911A Expired - Fee Related KR100221031B1 (ko) 1991-06-24 1992-06-23 생물학적으로 활성 단백질, 펩티드 또는 폴리펩티드를 함유하는 이식재 조성물 및 그의 제조 방법

Country Status (24)

Country Link
EP (1) EP0523330B1 (enExample)
JP (1) JP3597205B2 (enExample)
KR (1) KR100221031B1 (enExample)
CN (1) CN1050301C (enExample)
AT (1) ATE135565T1 (enExample)
AU (1) AU656200B2 (enExample)
BR (1) BR9202374A (enExample)
CA (1) CA2071757C (enExample)
DE (1) DE69209173T2 (enExample)
DK (1) DK0523330T3 (enExample)
ES (1) ES2087337T3 (enExample)
GE (1) GEP19970992B (enExample)
GR (1) GR3019457T3 (enExample)
HU (1) HU217547B (enExample)
IE (1) IE74398B1 (enExample)
IL (1) IL102287A (enExample)
LV (1) LV11816B (enExample)
MD (1) MD1394G2 (enExample)
MX (1) MX9203175A (enExample)
RU (1) RU2080119C1 (enExample)
SG (1) SG47955A1 (enExample)
TW (1) TW215058B (enExample)
UA (1) UA26137C2 (enExample)
ZA (1) ZA924613B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
MXPA01000674A (es) * 1998-07-20 2002-04-08 Peptech Ltd Formulacion de bioimplante.
JP2001058955A (ja) * 1999-06-17 2001-03-06 Inst Of Physical & Chemical Res 生理活性ペプチド徐放性製剤
AU2001238540A1 (en) 2000-02-24 2001-09-03 Monsanto Technology Llc Non-aqueous injectable formulations for extended release of somatotropin
WO2002000261A2 (en) 2000-06-26 2002-01-03 Monsanto Technology Llc Surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
JP4931282B2 (ja) * 2000-10-02 2012-05-16 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
SE526959C2 (sv) * 2003-10-02 2005-11-29 Tikomed Ab Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
JP2005145821A (ja) * 2003-11-11 2005-06-09 Kao Corp 打錠製剤
US20120283171A1 (en) 2009-12-21 2012-11-08 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
EA201290542A1 (ru) 2009-12-21 2013-07-30 Амбркс, Инк. Модифицированные свиные соматотропиновые полипептиды и их применение

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
HUT69680A (en) * 1990-08-09 1995-09-28 Endocon Inc Implant and apparatus for delivering multiple drug and process for production of theese

Also Published As

Publication number Publication date
HU9202092D0 (en) 1992-09-28
AU656200B2 (en) 1995-01-27
JP3597205B2 (ja) 2004-12-02
IE74398B1 (en) 1997-07-30
GEP19970992B (en) 1997-11-20
HUT61486A (en) 1993-01-28
CN1068965A (zh) 1993-02-17
MD1394F2 (en) 2000-01-31
CA2071757A1 (en) 1992-12-25
DE69209173T2 (de) 1996-11-28
KR930000131A (ko) 1993-01-15
IL102287A (en) 2000-06-01
BR9202374A (pt) 1993-01-26
ES2087337T3 (es) 1996-07-16
IE922020A1 (en) 1992-12-30
EP0523330A1 (en) 1993-01-20
UA26137C2 (uk) 1999-06-07
DE69209173D1 (de) 1996-04-25
ZA924613B (en) 1993-03-31
AU1847092A (en) 1993-01-07
EP0523330B1 (en) 1996-03-20
RU2080119C1 (ru) 1997-05-27
HU217547B (hu) 2000-02-28
GR3019457T3 (en) 1996-06-30
MD940370A (en) 1996-06-28
LV11816A (lv) 1997-08-20
CN1050301C (zh) 2000-03-15
TW215058B (enExample) 1993-10-21
MD1394G2 (ro) 2000-11-30
JPH05186363A (ja) 1993-07-27
ATE135565T1 (de) 1996-04-15
MX9203175A (es) 1993-04-01
LV11816B (en) 1997-12-20
IL102287A0 (en) 1993-01-14
SG47955A1 (en) 1998-04-17
CA2071757C (en) 2003-06-10
DK0523330T3 (da) 1996-04-15

Similar Documents

Publication Publication Date Title
US5091185A (en) Coated veterinary implants
KR100221031B1 (ko) 생물학적으로 활성 단백질, 펩티드 또는 폴리펩티드를 함유하는 이식재 조성물 및 그의 제조 방법
JP2966564B2 (ja) 非経口投与用の安定な組成物とその製法
DE68929273T2 (de) Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
CA2125148C (en) A carbohydrate glass matrix for the sustained release of a therapeutic agent
NZ243221A (en) Implantable medicament composition for the sustained release of proteinaceous substance
HK1000004B (en) Stable compositions for parenteral administration and method of making same
PL161857B1 (pl) do pozajelitowego podawania somatotropiny zwierzeciu PL PL PL
JPS6348223A (ja) 非経口投与のための組成物及びその使用
US5156851A (en) Coated veterinary implants
US5662917A (en) Release-controlled implantable somatotropin composition
US5801141A (en) Implant compositions containing a biologically active protein, peptide or polypeptide
US5232708A (en) Coated veterinary implants
NZ215730A (en) Sustained-release peptide compositions containing proteins as carriers
EP0314421A1 (en) Somatotropin formulations

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20030417

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20040625

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20040625

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000